Estrogen and cardiovascular disease: Aging and estrogen loss at the heart of the matter?

Future Cardiology

Volumn 8, Issue 1, 2012, Pages 9-12

  Knowlton, Anne A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiac myocytes; estrogen; heart; inflammation; ROS; vascular function

Indexed keywords

CD11B ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ETANERCEPT; GELATINASE A; GUANYLATE CYCLASE; HEAT SHOCK PROTEIN 72; HEAT SHOCK TRANSCRIPTION FACTOR 1; INTERLEUKIN 6; MADD PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; RALOXIFENE; REACTIVE OXYGEN METABOLITE; SCLEROPROTEIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STAT3 PROTEIN; TAMOXIFEN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

AGING; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ADHESION; CELL DEATH; CELL PROLIFERATION; CONTROLLED CLINICAL TRIAL (TOPIC); DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; ESTROGEN THERAPY; EVIDENCE BASED MEDICINE; GENE EXPRESSION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE RELAXATION; HUMAN; HYPERTENSION; MENOPAUSE; MONOCYTE; NONHUMAN; OUTCOME ASSESSMENT; OVARIECTOMY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; RHEUMATOID ARTHRITIS;

AGING; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; ESTROGENS; FEMALE; HUMANS; NITRIC OXIDE SYNTHASE; POSTMENOPAUSE; RISK FACTORS; WORLD HEALTH;

EID: 84555202676     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.11.84     Document Type: Review

References (19)

1. Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280, 605-613 (1998). (Pubitemid 28502636)
2. Writing Group for the Women's Health Initiative Investigators. Risks and benefts of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 288, 321-333 (2002).
3. Dubey RK, Imthurn B, Barton M, Jackson EK. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 66, 295-306 (2005). (Pubitemid 40471044)
4. Grodstein F, Clarkson T, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. N. Engl. J. Med. 348, 645-650 (2003). (Pubitemid 36204960)
5. Stice JP, Chen L, Kim SC et al. 17b-Estradiol, aging, infammation and the stress response in the female heart. Endocrinology 152, 1589-1598 (2011).
6. Ungvari Z, Labinskyy N, Gupte S et al. Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats. Am. J. Physiol. Heart Circ. Physiol. 294, H2121-H2128 (2008).
7. Podlutsky A, Ballabh P, Csiszar A. Oxidative stress and endothelial dysfunction in pulmonary arteries of aged rats. Am. J. Physiol. Heart Circ. Physiol. 298, H346-H351 (2010).
8. Kim KH, Bender JR. Membrane-initiated actions of estrogen on the endothelium Mol. Cell. Endocrinol. 308, 3-8 (2009).
9. Chambliss KL, Wu Q, Oltmann S et al. Non-nuclear estrogen receptor-a signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J. Clin. Invest. 120, 2319-2330 (2010).
10. LeBlanc AJ, Reyes R, Kang LS et al. Estrogen replacement restores fow-induced vasodilation in coronary arterioles of aged and ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297, R1713-R1723 (2009).
11. Arenas IA, Armstrong SJ, Xu Y, Davidge ST. Chronic tumor necrosis factor-alpha inhibition enhances no modulation of vascular function in estrogen-defcient rats. Hypertension 46, 76-81 (2005). (Pubitemid 40946494)
12. Voloshenyuk TG, Gardner JD. Estrogen improves TIMP-MMP balance and collagen distribution inn volume-overloaded hearts of ovariectomized females. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R683-R693 (2010).
13. Zhou L, Shao Y, Huang Y, Yao T, Lu LM. 17b-Estradiol inhibits angiotensin II-induced collagen synthesis of cultured rat cardiac fbroblasts via modulating angiotensin II receptors. Eur. J. Pharmacol. 567, 186-192 (2007). (Pubitemid 46976891)
14. Pedram A, Razandi M, O'Mahony F, Lubahn D, Levin ER. Estrogen receptor-beta prevents cardiac fbrosis. Mol. Endocrinol. 24, 2152-2165 (2010).
15. Babiker FA, Lips D, Meyer R et al. Estrogen receptor b protects the murine heart against left ventricular hypertrophy. Arterioscler. Thromb. Vasc. Biol. 26, 1524-1530 (2006). (Pubitemid 44288978)
16. Fliegner D, Schubert C, Penkalla A et al. Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in presssure overload. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R1597-R1606 (2010).
17. Pedram A, Razandi M, Lubahn D et al. Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-b to inhibit calcineurin. Endocrinology 149, 3361-3369 (2008). (Pubitemid 351919609)
18. Pechenino AS, Lin L, Mbai FN et al. Impact of aging vs. Estrogen loss on cardiac gene expression: late estrogen replacement and infammation. Physiol. Genomics 43, 1065-1073 (2011).
19. Deschamps AM, Murphy E, Sun J. Estrogen receptor activation and cardioprotection in ischemia reperfusion injury Trends Cardiovasc. Med. 20, 73-78 (2010).